Course of viral load throughout HIV-1 infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 23, Issue 2, 2000, Pages 172-177

  Sabin, Caroline A ^a   Devereux, Helen ^a   Phillips, Andrew N ^a   Hill, Andrew ^b   Janossy, George ^a   Lee, Christine A ^a   Loveday, Clive ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

CD4+ T cell count; Hemophilia; HIV 1 RNA; Natural history; Prognosis; Viral load

Indexed keywords

DIDANOSINE; LAMIVUDINE; STAVUDINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISEASE COURSE; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RNA ANALYSIS; SCHOOL CHILD; SEROCONVERSION; VIRUS LOAD; VIRUS PATHOGENESIS;

EID: 0034144121     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200002010-00009     Document Type: Article

References (32)

1. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1997;272:1167-70.
2. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991;324:961-4.
3. Semple M, Loveday C, Weller I, Tedder R. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J Med Virol 1991;35:38-45.
4. Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Virologie and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-8.
5. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-16.
6. + T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 1990;113:438-43.
7. Piatak M Jr, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:149-54.
8. Henrard DR, Daar E, Farzadegan H, et al. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:305-10.
9. Ho, DD. Viral counts count in HIV infection [editorial]. Science 1996;272:1124-5.
10. Henrard DR, Phillips JF, Muenz LR, et al. Natural history of HIV-1 cell-free viremia. JAMA 1995;274:554-8.
11. O'Brien TR, Rosenberg PS, Yellin F, Goedert JJ. Longitudinal HIV-1 RNA levels in a cohort of homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:155-61.
12. Lee CA, Phillips A, Elford J, et al. The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol 1989;73:228-34.
13. Sabin C, Phillips A, Elford J, Griffiths P, Janossy G, Lee C. The progression of HIV disease in a haemophilic cohort followed for 12 years. Br J Haematol 1993;83:330-3.
14. Mercolino TJ, Connelly MC, Meyer EJ, et al. Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: a new concept for absolute T cell subset determinations. Cytometry 1995;22:48-59.
15. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-74.
16. McNeil AJ, Gore SM. Statistical analysis of zidovudine (AZT) effect on CD4 cell counts in HIV disease. Stat Med 1996;15:75-92.
17. Phillips AN, Lee CA, Elford J, Janossy G, Kernoff PBA. The cumulative risk of AIDS as the CD4 lymphocyte count declines. J Acquir Imm Defic Syndr 1992;5:148-52.
18. Rasbash J, Woodhouse G. MLn command reference, version 1.0a. London: Multilevel Models Project, Institute of Education, University of London, 1996.
19. SAS Institute Inc. SAS/STAT user's guide, version 6. Cary, NC: SAS Institute Inc., 1992.
20. + T-cell depletion in asymptomatic patients. Infection 1996;24:245-7.
21. Galetto-Lacour A, Yerly S, Perneger TV, Baumberger C, Hirschel B, Perrin L. Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. J Infect Dis 1996;173:1388-93.
22. Garbuglia AR, Salvi R, Di Caro A, et al. In vitro activation of HIV RNA expression in peripheral blood lymphocytes as a marker to predict the stability of non-progressive status in long-term survivors. AIDS 1996;10:17-21.
23. Keet IPM, Janssen M, Veugelers PJ, et al. Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years. J Infect Dis 1997;176:665-71.
24. Kernoff PBA, Lee CA, Karayiannis P, Thomas HC. High risk of non-A, non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. Br J Haematol 1985;60:469-79.
25. Sabin CA, Telfer P, Phillips AN, Bhagani S, Lee CA. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J Infect Dis 1997;175:164-8.
26. de Biasi R, Rocino A, Miraglia E, Mastrullo L, Quirino AA. The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized prospective, two-year comparison with an intermediate purity concentrate. Blood 1991;78:1919-22.
27. BHIVA Guidelines Co-ordinating Committee. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1997;349:1086-92.
28. Eyster ME, Gail MH, Ballard JO, Al-Mondhiry H, Goedert JJ. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med 1987;107:1-6.
29. Phillips AN, Lee CA, Elford J, et al. More rapid progression to AIDS in older HIV-infected people: the role of the CD4- T-cell counts. J Acquir Imm Defic Syndr 1991;4:970-5.
30. O'Brien TR, Blattner WA, Waters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996;276:105-10.
31. Coombs RW, Henrard DR, Mehaffey WF, et al. Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol 1993;31:1980-6.
32. Halfon P, Khiri H, Gerolami V, et al. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. J Hepatol 1996;25:307-11.